1. An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients

   Wei, J., Rybczynska, A. A., Meng, P., Terpstra, M., Saber, A., Sietzema, J., Timens, W., Schuuring, E., Hiltermann, T. J. N., Groen, H. J. M., van der Wekken, A. J., van den Berg, A. & Kok, K., 1-Oct-2020, In : Cancers. 12, 10, 17 p., 2843.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Microsieves for the detection of circulating tumor cells in leukapheresis product in non-small cell lung cancer patients

   Tamminga, M., Oomens, L., Hiltermann, T. J. N., Andree, K. C., Tibbe, A., Broekmaat, J., Schuuring, E., Terstappen, L. W. M. M. & Groen, H. J. M., Aug-2020, In : Translational lung cancer research. 9, 4, p. 1093-1100 10 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer

   Perakis, S. O., Weber, S., Zhou, Q., Graf, R., Hojas, S., Riedl, J. M., Gerger, A., Dandachi, N., Balic, M., Hoefler, G., Schuuring, E., Groen, H. J. M., Geigl, J. B., Heitzer, E. & Speicher, M. R., Sep-2020, In : ESMO Open. 5, 5, 11 p., e000872.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)

   Ramdani, H., Falk, M., Schatz, S., Tiemann, M., Heukamp, L. C., Schuuring, E., Groen, H. J. & Griesinger, F., 2019, In : Oncology Research and Treatment. 42, p. 77-77 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

5. "The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology": letter to the Editor

   Dinjens, W. N. M., Ligtenberg, M. J. L., van Wezel, T., Schuuring, E. & Dubbink, H. J., 6-Aug-2020, In : Virchows Archiv. 2 p.

   Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

View all (242) »

1. Dataset: Inter-laboratory agreement of the Cervista HPV HR test with a second cut-off at default setting of 1.93 (A) and at new setting of 5.0 (B)

   Boers, A. (Creator), Slagter-Menkema, L. (Creator), Hemel, van, B. (Creator), Belinson, J. L. (Creator), Ruitenbeek, T. (Creator), Buikema, H. (Creator), Klip, H. (Creator), Ghyssaert, H. (Creator), Zee, van der, A. (Creator), Bock, de, T. (Creator), Schuurs-Wisman, B. (Creator), Schuuring, E. (Creator), University of Groningen, 22-Jul-2014

   DOI: https://doi.org/10.1371/journal.pone.0101930.t006

   Dataset

View all (1) »

1. Circulating plasma DNA biomarker

   Ed Schuuring (Invited speaker)

   30-Apr-2015

   Activity: Talk or presentation › Academic

2. De longkankercel, kennis vanuit de medisch pathologische oncologie

   Ed Schuuring (Invited speaker)

   17-Apr-2015

   Activity: Talk or presentation › Professional

3. Basale moleculaire biologie in onze diagnostiek

   Ed Schuuring (Invited speaker)

   30-Sep-2015 → 1-Oct-2015

   Activity: Talk or presentation › Professional

View all (80) »

1. (Moleculair) diagnostisch onderzoek bij de Pathologie kan nieuwe behandelmogelijkheden bieden voor longkankerpatiënten.

   Wim Timens & Ed Schuuring

   16/11/2019

   1 Media contribution

   Press/Media: Expert Comment › Popular

2. 3D-eiwit model van nieuwe genetische veranderingen in een tumormutaties draagt bij aan een betere voorspelling van de effectiviteit van longkanker behandeling.

   Wim Timens & Ed Schuuring

   12/11/2019

   1 Media contribution

   Press/Media: Expert Comment › Popular

3. diagnostisch onderzoek naar longkanker kan nieuwe/betere behandelmethode bieden

   Ed Schuuring

   11/11/2019 → 12/11/2019

   2 Media contributions

   Press/Media: Expert Comment › Professional

View all (8) »